title: L1210 cells selected for resistance to methoxymorpholinyl doxorubicin appear specifically resistant to this class of morpholinyl derivatives.
abstract: We investigated the mechanism of resistance in murine L1210 leukaemia cells selected after treatment with FCE 23762 methoxymorpholinyl doxorubicin: (MMRDX), a methoxymorpholinyl derivative of doxorubicin active in vitro and in vivo on multidrug-resistant (mdr) cells, currently undergoing phase I clinical trials. The resistant subline obtained after repeated in vitro treatments, L1210/MMRDX, is resistant in vitro and in vivo to all tested methoxymorpholinyl derivatives and to cyanomorpholinyl doxorubicin, but shows resistance to morpholinyl derivatives only in vivo or following their activation with rat S9-liver fractions in vitro. L1210/MMRDX cells are sensitive to classic mdr- and altered topoisomerase (AT)-mdr-associated drugs. These cells do not appear to overexpress the mdr1 gene, nor do they exhibit impaired intracellular drug accumulation and efflux or altered levels of glutathione and glutathione S-transferase. The extent of DNA single-strand break formation and, after microsomal activation, of DNA interstrand cross-links after treatment with MMRDX was similar in the parent and the resistant subline. The mechanism of resistance in L1210/MMRDX cells remains to be identified but may prove a novel one, highly specific for this class of mdr-active anthracyclines.
authors.affiliation: Farmitalia Carlo Erba, Research Center, R&D Experimental Oncology Laboratory, Nerviano MI, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Geroni
authors.forename: E
authors.initials: E
authors.lastname: Pesenti
authors.forename: M
authors.initials: M
authors.lastname: Broggini
authors.forename: G
authors.initials: G
authors.lastname: Belvedere
authors.forename: G
authors.initials: G
authors.lastname: Tagliabue
authors.forename: M
authors.initials: M
authors.lastname: D'Incalci
authors.forename: G
authors.initials: G
authors.lastname: Pennella
authors.forename: M
authors.initials: M
authors.lastname: Grandi
mesh_terms: D000818:Animals; D004273:DNA, Neoplasm / Q000378:metabolism*; D004317:Doxorubicin / Q000031:analogs & derivatives* / Q000378:metabolism; D004351:Drug Resistance; D005260:Female; D005978:Glutathione / Q000032:analysis; D007939:Leukemia L1210 / Q000378:metabolism*; D051379:Mice; D008811:Mice, Inbred DBA; D008815:Mice, Inbred Strains; D014407:Tumor Cells, Cultured
chemical_list: D004273:DNA, Neoplasm; C066998:methoxy-morpholinyl-doxorubicin; D004317:Doxorubicin; D005978:Glutathione